There is something almost paradoxical about an ancient system of healing becoming one of the fastest-growing sectors in modern global healthcare. Traditional Chinese Medicine, or TCM, has roots stretching back more than two millennia. Yet in 2026, it is attracting serious investment, scientific scrutiny, and mainstream patients in countries that would once have dismissed it as folklore.
What is driving this surge? Is it desperation, cultural curiosity, or is something deeper going on? The answers, as it turns out, are far more compelling than most people expect. Let’s dive in.
A Market That Is Simply Exploding
Let’s start with the numbers, because they are genuinely striking. The global TCM market, valued at USD 282.36 billion in 2026, is expected to climb to USD 513.6 billion by 2035 at a CAGR of 6.87% during the forecast period. That is not a niche industry quietly bubbling along. That is a global economic force.
Rising chronic disease prevalence drives roughly more than half of TCM adoption, emphasizing holistic healthcare and wellness practices worldwide. Think about that for a moment. People are not turning to herbal medicine and acupuncture because it is trendy. Many are doing it because conventional medicine has left them without satisfying answers for conditions that linger for years.
By therapy type, herbal medicine led with nearly 59% revenue share in 2024, while acupuncture posts the strongest growth outlook at 8.45% CAGR heading toward 2030. These two pillars of TCM are clearly resonating with a global audience in very different ways, and neither shows signs of slowing down.
TCM Is Practiced in More Countries Than You Might Expect
Here is a fact that genuinely surprised me when I first came across it. TCM is gaining popularity worldwide and is today practiced in over 183 countries and regions, with more than 80,000 TCM clinics now operating outside China. That is an enormous international footprint for a practice that is still often described as “alternative” in Western media.
Some 170 of WHO’s 194 Member States have reported on the use of herbal medicines, acupuncture, yoga, indigenous therapies and other systems of traditional medicine. When nearly every country on the planet is at least acknowledging TCM in some capacity, you cannot really call it fringe anymore.
According to the Chinese Ministry of Commerce, over 420,000 tons of TCM formulations were distributed to hospitals and clinics in China in 2022, and the number of registered TCM practitioners increased to 420,000 in 2023 according to the National Health Commission of China. These figures signal deep institutional integration, not just casual interest.
The World Health Organization Takes a Clear Stance
Honestly, one of the most significant developments in recent years has been the World Health Organization’s increasingly firm endorsement of traditional medicine. Traditional medicine was in the spotlight during the 78th World Health Assembly in May 2025 in Geneva, with delegates emphasizing research, innovation, regulation, equity and collaboration, and a major milestone was achieved when Member States agreed on the new WHO Global Traditional Medicine Strategy 2025 to 2034.
The WHO Global Traditional Medicine Strategy 2025 to 2034 aims to enhance the contribution of traditional, complementary, and integrative medicine to achieving universal health coverage by strengthening the integration of evidence-based traditional medicine into national health systems, prioritizing research to build robust evidence, establishing regulatory mechanisms to ensure safety and quality, and promoting integration into healthcare services.
The World Health Organization is working closely with China to support traditional medicine, and from 2024 to 2028 they will invest five million US dollars in WHO’s program for traditional and integrative medicine, focusing on setting global standards and improving regulation to help TCM earn wider recognition and easier integration with mainstream healthcare systems. That kind of institutional commitment matters enormously for the long-term trajectory of the field.
Chronic Disease Is Reshaping What Patients Want
Here is the thing. Modern medicine is extraordinarily good at acute care. Heart attacks, infections, trauma. But for conditions that drag on for years, patients often feel underserved. Global diabetes, cardiovascular, and cancer incidence escalates with aging demographics, prompting health systems to seek preventive, multi-modal therapies. TCM positions itself almost perfectly as an answer to exactly that gap.
Traditional medicine emphasizes prevention and balance – body, mind, and environment – while addressing lifestyle and psychosocial factors often overlooked in conventional treatment, and therapies like acupuncture, herbal medicine, and yoga are increasingly used alongside biomedical interventions to ease pain, reduce side effects, and improve quality of life for chronic conditions.
Research has found cost-effective outcomes for interventions including acupuncture for migraine and manual therapy for neck pain, among other conditions. These are not obscure or speculative claims. They are findings from peer-reviewed literature that researchers are now actively building upon. Pain management, it’s worth noting, accounted for over 27% of the TCM market in 2024 by application segment.
Artificial Intelligence Is Unlocking TCM’s Scientific Potential
If there is one development that could truly transform how the world views TCM, it is the collision of ancient herbal knowledge with modern artificial intelligence. It sounds almost science-fictional, but it is already happening in labs around the world right now.
The pursuit of groundbreaking healthcare innovations has led to the convergence of artificial intelligence and TCM, marking a new frontier that demonstrates the promise of combining the advantages of ancient healing practices with cutting-edge advancements in modern technology.
In recent years, AI technologies, particularly machine learning and deep learning, have demonstrated significant potential in pharmacological research on TCM. Due to the complexity of TCM compositions, targets, and pathways, conventional experimental methods encounter limitations in analyzing dose-response relationships and synergistic mechanisms, but AI with its advanced learning and data-processing capabilities enables the integration of complex information, thereby enhancing the systematic approach, efficiency, and accuracy of research.
Recent studies indicate that AI can play a key role in monitoring the production process of TCM, accelerating the development of intelligent manufacturing and ensuring stringent quality control, and by harnessing the capabilities of AI it is possible to rapidly screen and classify effective ingredients based on their chemical properties and herbal characteristics. Think of it like giving a centuries-old recipe book to the most powerful algorithm ever built. The insights that emerge are genuinely new territory.
Regulatory Momentum Is Building Around the World
One of the real barriers to TCM’s wider adoption has always been regulatory uncertainty. Patients and clinicians want assurances of safety and efficacy. Governments want standardized frameworks. Slowly but clearly, that picture is changing.
China’s 2024 update to its Basic Medical Insurance Drug Directory, effective January 2025, harmonizes reimbursement for countless formulations while erasing regional access disparities, and South Korea’s parallel inclusion strategy confirms a broader policy arc prioritizing cost-effective chronic-disease management, with reimbursement removing consumer cost barriers and creating steady demand for regulated manufacturers.
China is pushing to set 180 domestic and 30 international standards by 2026 to anchor export credibility. That is a concrete, time-bound commitment with real commercial consequences for global TCM supply chains.
High-quality randomized trials covering chronic pain, post-operative recovery, and mental health have intensified trust among clinicians and regulators, and institutional demand has stimulated guideline development, aligning dosage, technique, and safety metrics with Western protocols. There is still real work to do on quality control, it’s hard to say there aren’t genuine challenges, but the direction of travel is unmistakably toward greater rigor.
Western Markets Are Embracing TCM at a Surprising Scale
Perhaps the most quietly remarkable story in all of this is what is happening in North America and Europe. These are markets where skepticism of alternative medicine has historically run high. Yet the data tells a very different story in practice.
Nearly 10% of US adults have already experienced acupuncture, and roughly 60% say they would opt for treatment when covered by insurance. That is a latent demand of enormous proportions, held back largely by cost rather than reluctance. Once insurance widens coverage, usage could expand dramatically.
North America held more than 40% of global TCM revenue with a market size of around 87.8 billion USD in 2024, driven by growing consumer interest in holistic healthcare. Europe is not far behind. The European market for TCM is expanding and becoming more widely accepted as regulations are put in place and benefits are more widely acknowledged, and the UK TCM market alone held a share of over 11 billion USD in 2024 projected to grow at a notable rate.
In April 2024, Rohto Pharmaceutical and Mitsui completed the acquisition of Eu Yan Sang International, a well-established TCM brand, for roughly 594 million US dollars, a company that operates over 170 retail stores and 30 herbal medicine clinics across Malaysia, Hong Kong, and Singapore. When major pharmaceutical investors make moves like that, it tells you something essential about where confidence in this sector truly lies.
—
Traditional Chinese Medicine is no longer a story confined to the clinic walls of Beijing or Shanghai. It is a living, evolving discipline that is being reshaped by technology, legitimized by global health institutions, and embraced by patients who are simply looking for something more complete than what they have been offered. Whether it fully integrates into Western healthcare systems or carves its own lane alongside them, one thing seems increasingly clear: it is not going away. What do you think about the future of TCM in your own healthcare choices? Share your thoughts in the comments.